Literature DB >> 22025650

The efficacy and cost-effectiveness of statins in low-risk patients.

Ajay K Gupta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22025650      PMCID： PMC3216454          DOI： 10.1503/cmaj.111674

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K.

Authors:  Peter S Sever; Choon L Chang; Ajay K Gupta; Andrew Whitehouse; Neil R Poulter
Journal:  Eur Heart J       Date:  2011-08-28       Impact factor: 29.983

Review 2.  Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis.

Authors:  Marcello Tonelli; Anita Lloyd; Fiona Clement; Jon Conly; Don Husereau; Brenda Hemmelgarn; Scott Klarenbach; Finlay A McAlister; Natasha Wiebe; Braden Manns
Journal:  CMAJ       Date:  2011-10-11       Impact factor: 8.262

3.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

Review 4.  Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.

Authors:  Kausik K Ray; Sreenivasa Rao Kondapally Seshasai; Sebhat Erqou; Peter Sever; J Wouter Jukema; Ian Ford; Naveed Sattar
Journal:  Arch Intern Med       Date:  2010-06-28

5.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Authors:  James Shepherd; Gerard J Blauw; Michael B Murphy; Edward L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; A Edo Meinders; John Norrie; Chris J Packard; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

Review 6.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Kirsten Ward; Theresa Hm Moore; Margaret Burke; George Davey Smith; Juan-Pablo Casas; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

7.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

Review 8.  The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials.

Authors:  J J Brugts; T Yetgin; S E Hoeks; A M Gotto; J Shepherd; R G J Westendorp; A J M de Craen; R H Knopp; H Nakamura; P Ridker; R van Domburg; J W Deckers
Journal:  BMJ       Date:  2009-06-30

9.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

10.  Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.

Authors:  Jane Armitage; Louise Bowman; Karl Wallendszus; Richard Bulbulia; Kazem Rahimi; Richard Haynes; Sarah Parish; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.